Benjamin F. Edwards & Company, Inc. Exact Sciences Corp Transaction History
Benjamin F. Edwards & Company, Inc.
- $5.69 Billion
- Q2 2024
A detailed history of Benjamin F. Edwards & Company, Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, Benjamin F. Edwards & Company, Inc. holds 25 shares of EXAS stock, worth $1,404. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25
Previous 452
94.47%
Holding current value
$1,404
Previous $31,000
96.77%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding EXAS
# of Institutions
645Shares Held
157MCall Options Held
1.74MPut Options Held
1.56M-
Capital World Investors Los Angeles, CA17.8MShares$1 Billion0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.6MShares$991 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12.5MShares$702 Million0.11% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$678 Million0.01% of portfolio
-
State Street Corp Boston, MA6.61MShares$372 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $9.94B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...